BMSF Clinical Investigator Pipeline Program (BMSF CIPP)
As part of the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP), the BMSF Clinical Investigator Pipeline Program (CIPP) is a summer service-learning externship designed to expose talented medical students (MD, DO, MD/PhD, DO/PhD) of diverse backgrounds to clinical research in community-based clinical research settings (e.g., community health centers, safety net hospitals, clinical research organizations).
The BMSF CIPP offers a distinctive approach to increasing diversity in clinical trials by offering rising second-year medical students a 6-week intensive and immersive summer service-learning experience in communities where underrepresented patients receive care. BMSF CIPP students gain exposures to clinical research, acquire community engagement and leadership skills, and are mentored by early-stage clinical investigators participating in the BMSF DCTCDP.
BMSF CIPP Students each receive a $5,000 scholarship stipend to cover travel, living, and lodging expenses during the service-learning period.
The 2022 BMSF CIPP
- June 13 to July 22, 2022
- Atlanta, GA
- New Orleans, LA
- San Antonio, TX
- Seattle, WA
- St. Louis, MO
- 2022 Applications will open on November 15, 2021, and close January 28, 2022, at 11:59pm Eastern Time
- Award Notification: March 21, 2022*
* Dates are subject to change.
Click here to start an application: https://nmf.smapply.io/prog/bmsfcippcohort1
BMSF CIPP candidates must meet the following eligibility:
- Rising second-year medical student in an accredited US medical school
- Student underrepresented in medicine**
- US citizen or Deferred Action for Childhood Arrivals (DACA) status
** NMF designates the following racial/ethnic groups as underrepresented student in healthcare: African American/Black, Hispanic/Latino, American Indian or Alaska Native, Asian American (Vietnamese and Cambodian only), Native Hawaiian or Other Pacific Islander.
Please visit the program website for more information: www.diversityinclinicaltrials.org.